BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31050003)

  • 21. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.
    Popovics P; Schally AV; Salgueiro L; Kovacs K; Rick FG
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1359-1364. PubMed ID: 28123062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
    Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
    Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling Role of Adipocyte Leptin in Prostate Cell Proliferation Induced by Trichomonas vaginalis.
    Kim JH; Han IH; Shin SJ; Park SY; Chung HY; Ryu JS
    Korean J Parasitol; 2021 Jun; 59(3):235-249. PubMed ID: 34218595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
    Maxwell PJ; Neisen J; Messenger J; Waugh DJ
    Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
    Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
    Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carica papaya leaf extract inhibits prostatitis-associated prostatic hyperplasia via the TRAF6/TAK1/MEK/NF-κB pathway.
    Jin BR; Ju JY; Nugroho A; Lee M; An HJ
    Biomed Pharmacother; 2021 Mar; 135():111197. PubMed ID: 33433362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cell tryptase-PAR2 pathway in proliferation of prostatic stromal cells reacted with Trichomonas vaginalis.
    Noh CS; Chung HY; Han IH; Kim JH; Kim YM; Ryu JS
    Parasite Immunol; 2021 Aug; 43(8):e12868. PubMed ID: 33991355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifaceted impact of adipose conditioned media: Obesity-driven promotion of prostate cancer and cancer stem cell dynamics.
    Erdogan S; Serttas R; Dibirdik I; Turkekul K
    Cell Biochem Funct; 2024 Mar; 42(2):e3979. PubMed ID: 38481004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
    Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
    Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Debelec-Butuner B; Alapinar C; Varisli L; Erbaykent-Tepedelen B; Hamid SM; Gonen-Korkmaz C; Korkmaz KS
    Mol Carcinog; 2014 Feb; 53(2):85-97. PubMed ID: 22911881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretion.
    Yu Y; Zhang Q; Ma C; Yang X; Lin R; Zhang H; Liu Y; Han Z; Cheng J
    Stem Cell Res Ther; 2018 Sep; 9(1):242. PubMed ID: 30257726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
    Wang W; Bergh A; Damber JE
    Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
    Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
    Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-κB pathway.
    Zhang J; Kuang Y; Wang Y; Xu Q; Ren Q
    Apoptosis; 2017 Jun; 22(6):877-884. PubMed ID: 28374086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration.
    Khusbu FY; Zhou X; Roy M; Chen FZ; Cao Q; Chen HC
    Int J Biochem Cell Biol; 2020 Jan; 118():105644. PubMed ID: 31712163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation induced by lipopolysaccharide advanced androgen receptor expression and epithelial-mesenchymal transition progress in prostatitis and prostate cancer.
    Wang GC; Huang TR; Wang KY; Wu ZL; Xie JB; Zhang HL; Yin L; Tang WL; Peng B
    Transl Androl Urol; 2021 Nov; 10(11):4275-4287. PubMed ID: 34984192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trichomonas vaginalis exosomes deliver cargo to host cells and mediate host∶parasite interactions.
    Twu O; de Miguel N; Lustig G; Stevens GC; Vashisht AA; Wohlschlegel JA; Johnson PJ
    PLoS Pathog; 2013; 9(7):e1003482. PubMed ID: 23853596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.